Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
about
Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateCentral nervous system graft-versus-host disease: report of two cases and literature review.Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategiesA new model of LMP1-MYC interaction in B cell lymphoma.A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.Infiltrating ductal carcinoma of the breast associated with primary breast lymphoma.Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.Lymphomatoid granulomatosis with spinal involvement after childhood acute lymphoblastic leukemia.Enhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma.Adoptive T-cell transfer in cancer immunotherapy.Posttransplant lymphoproliferative disease after lung transplantation.Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma.Immunotherapy targeting EBV-expressing lymphoproliferative diseasesEpstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.Immunotherapy for epstein-barr virus-related lymphomas.T-cell therapies for Epstein-Barr virus-associated lymphomas.Cellular immune therapy for viral infections in transplant patientsAdoptive therapy for EBV-induced cancers: driving success with post-transplant lymphoproliferative disorder to other EBV-derived tumors.RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency.Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.Immunotherapy against cancer-related viruses.A Rare Case of Three Distinct Epstein-Barr Virus Associated Lymphoproliferative Disorders Over Sixteen Years of Human Immunodeficiency Virus Infection.[Cerebral lymphomatoid granulomatosis. A case report].A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivoViral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant.Felis Catus Gammaherpesvirus 1 DNAemia in Whole Blood from Therapeutically Immunosuppressed or Retrovirus-Infected Cats.Clonal Epstein-Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression.Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation.Current Progress in EBV-Associated B-Cell Lymphomas.Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity.
P2860
Q27318672-B1F33267-03C8-4A74-AC69-90B284C30B99Q28388876-8498DC42-F3C9-4D22-8C4D-4CE80D56E5BDQ31076510-704C0B93-2233-4EC1-B6EE-6A6C9379FC20Q33713735-1060E995-EC64-4F37-B6E9-F5031618D03CQ34245230-9EE3E29C-9A50-435B-A322-D907C8B3E039Q34395376-1B16AD4A-9503-484A-888C-E14C31B72537Q34457976-1551BE4A-8565-46DF-9750-5CCCBDEEE9DEQ34751760-15022CCA-5F5A-41F3-B059-8C71AA576FD4Q35001573-7CCC6EA8-8710-4F20-A19A-F0C9E1188C84Q35005421-782C5E0A-0603-4D49-B251-CA18BF211C7FQ35068371-A1158BB1-BBD4-49F8-B81D-8DEDD45C9BE0Q35608342-A9689467-7A5F-4F47-9F7A-8B97DC5A07CBQ36334405-CF2D3E70-7ECB-4FAA-BF47-05AAE2383B09Q36471818-F5D82A05-9CED-43C9-8B55-595E5ADEC902Q36701511-6A0982F0-BFBF-40B1-9A21-8E16C78EAB57Q36784912-8985FAF9-126C-4020-B7D4-042DD6334836Q37152749-6A87BFA6-0F2C-4D32-9C5D-016D973ABD58Q37203558-527F661F-4824-473A-B4DB-ACC612D51FD8Q37268305-D832CFD2-6AE8-49F9-BBB4-FE56A21B928DQ37355725-58FF43BA-BC82-4F7B-8737-BF7F98205A2CQ37849461-0F357983-957F-415E-B64F-7AB5BC9765FEQ37854471-40A8985E-AAED-4C89-8853-AF409D2D8F2AQ37948940-802ADB2B-7CD1-4664-B5D7-B14E80E3A1DBQ38179174-82C0AF8B-DDE4-4D00-B05F-4FD88E3E116DQ38525041-62C37819-6E38-4516-8BD5-E53286A21EB4Q38716029-0E357644-66B9-492E-BB4D-B01A31693DFBQ38720593-F35E4D70-A1AF-494D-9DF1-69F9EAC13245Q38778924-B4E62E9A-C961-4AA5-A362-B543EB826B87Q40155239-97EA7B00-21B1-4C56-824E-B37AC2C140C5Q40460100-F47F99EF-EBCD-43FE-975C-F171D90A0E8BQ40529310-8B625BFA-63C8-46BF-A7E1-EF16CDE24AC2Q40628228-5F8074C1-B877-4484-935B-776CFFC71C9BQ42269563-A78B6A14-8459-453F-8FCA-090C02536B44Q43112302-1CD0BC75-7ED2-41A2-909C-4FFF53985BA8Q45344330-BE0880A7-BFAE-4DF1-B531-A31E38D952E8Q45351817-6AB861A8-3C7C-46EA-8698-7007C710F645Q45360061-49889A42-4FEF-435F-84F6-E6B3CE7A7EE0Q47606345-550A59BC-C733-440B-BF07-6FED16A33050Q47949375-E7CFA8ED-E743-4971-9C06-C5BD4772BDFBQ54212283-B620BB1F-6124-43D6-8F0F-8334E3F49942
P2860
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@en
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@nl
type
label
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@en
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@nl
prefLabel
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@en
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@nl
P1476
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
@en
P2093
Helen E Heslop
P304
P356
10.1182/ASHEDUCATION-2005.1.260
P577
2005-01-01T00:00:00Z